Poly(ADP-Ribose) Glycohydrolase Inhibition Sequesters NAD+ to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor Cells
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Poly(ADP-Ribose) Glycohydrolase Inhibition Sequesters NAD+ to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor Cells
Cancer Discov 2020 Nov 01;10(11)1672-1689, H Nagashima, CK Lee, K Tateishi, F Higuchi, M Subramanian, S Rafferty, L Melamed, JJ Miller, H Wakimoto, DP CahillFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.